JOHNSON DAVID EDWARD

CIK 00017855576 companiesNEW YORK, NY

SEC Profile

Transactions

Companies

Filings

CIK

0001785557

Recent Transactions

50 trades

Purchase
EXELIXIS, INC.$EXEL
Common Stock
2025-11-25$43.12/sh+27,532→ 1,553,262 total
Award
Liquidia Corp$LQDA
Common Stock, $0.001 par value per share ("Common Stock")
2025-06-17+18,396→ 38,755 total
Award
EXELIXIS, INC.$EXEL
Option (right to buy)
2025-05-29+21,464→ 21,464 total
Other
ALIMERA SCIENCES INC
Notional Derivative Agreements (obligation to buy)
2024-09-16−1→ 0 total
Other
ALIMERA SCIENCES INC
Common Stock, par value $0.01 per share ("Common Stock")
2024-09-16−16,835,154→ 0 total
Other
ALIMERA SCIENCES INC
Warrants
2024-09-16−800,000→ 0 total
Award
Liquidia Corp$LQDA
Common Stock, $0.001 par value per share ("Common Stock")
2024-09-12$8.90/sh+1,123,595→ 8,118,592 total
Purchase
Liquidia Corp$LQDA
Common Stock
2024-08-30$9.51/sh+150,000→ 6,994,997 total
Sale
Liquidia Corp$LQDA
Common Stock
2024-08-30$9.51/sh−150,000→ 6,844,997 total
Other
Liquidia Corp$LQDA
Common Stock, $0.001 par value per share ("Common Stock")
2024-08-30−3,440,948→ 6,994,997 total
Award
Liquidia Corp$LQDA
Common Stock, $0.001 par value per share ("Common Stock")
2024-06-20+20,359→ 20,359 total
Award
EXELIXIS, INC.$EXEL
Option (right to buy)
2024-05-31+42,767→ 42,767 total
Purchase
EXELIXIS, INC.$EXEL
Common Stock
2024-05-30$20.76/sh+225,000→ 1,525,730 total
Purchase
EXELIXIS, INC.$EXEL
Common Stock
2024-05-28$20.32/sh+200,000→ 1,300,730 total
Purchase
EXELIXIS, INC.$EXEL
Common Stock
2024-02-21$20.70/sh+190,000→ 1,100,730 total
Purchase
Liquidia Corp$LQDA
Common Stock, $0.001 par value per share ("Common Stock")
2023-12-14$7.16/sh+1,117,318→ 11,280,945 total
Sale
EXELIXIS, INC.$EXEL
Common Stock
2023-11-27$21.61/sh−120,409→ 790,321 total
Purchase
EXELIXIS, INC.$EXEL
Common Stock
2023-11-27$21.61/sh+120,409→ 910,730 total
Other
ALIMERA SCIENCES INC
Notional Derivative Agreements (obligation to buy)
2023-09-14+1→ 490,000 total
Purchase
ALIMERA SCIENCES INC
Common Stock
2023-09-14$3.39/sh+579,000→ 16,835,154 total
Sale
ALIMERA SCIENCES INC
Common Stock, par value 0.01 per share (Common Stock)
2023-09-14$3.39/sh−579,000→ 16,256,154 total
Conversion
ALIMERA SCIENCES INC
Series B Preferred
2023-08-15−2,924,761→ 0 total
Conversion
ALIMERA SCIENCES INC
Common Stock
2023-08-15$1.70/sh+13,431,616→ 16,835,154 total
Conversion
ALIMERA SCIENCES INC
Series B Preferred
2023-08-15−13,431,616→ 0 total
Conversion
ALIMERA SCIENCES INC
Common Stock, par value $0.01 per share ("Common Stock")
2023-08-15$2.10/sh+2,924,761→ 3,403,538 total
Other
STANDARD BIOTOOLS INC.$LAB
Common Stock
2023-07-03−670,466→ 7,797,454 total
Other
STANDARD BIOTOOLS INC.$LAB
Common Stock, $0.001 par value per share ("Common Stock")
2023-06-29−108,879→ 8,467,920 total
Award
Liquidia Corp$LQDA
Non-Qualified Stock Option (right to buy)
2023-06-19+20,000→ 20,000 total
Award
EXELIXIS, INC.$EXEL
Common Stock
2023-05-31+18,176→ 18,176 total
Award
EXELIXIS, INC.$EXEL
Option (right to buy)
2023-05-31+36,353→ 36,353 total
Purchase
Liquidia Corp$LQDA
Common Stock, $0.001 par value per share ("Common Stock")
2022-09-06$5.62/sh+250,000→ 10,643,627 total
Purchase
STANDARD BIOTOOLS INC.$LAB
Common Stock
2022-08-04$1.75/sh+255,173→ 11,444,836 total
Purchase
STANDARD BIOTOOLS INC.$LAB
Common Stock, $0.001 par value per share ("Common Stock")
2022-08-03$1.74/sh+46,009→ 11,189,663 total
Purchase
STANDARD BIOTOOLS INC.$LAB
Common Stock
2022-08-02$1.64/sh+272,618→ 11,143,654 total
Purchase
STANDARD BIOTOOLS INC.$LAB
Common Stock
2022-08-01$1.48/sh+210,200→ 10,871,036 total
Purchase
STANDARD BIOTOOLS INC.$LAB
Common Stock, $0.001 par value per share (Common Stock)
2022-07-29$1.42/sh+137,648→ 10,660,836 total
Award
Liquidia Corp$LQDA
Non-Qualified Stock Option (right to buy)
2022-06-17+20,000→ 20,000 total
Purchase
STANDARD BIOTOOLS INC.$LAB
Common Stock, $0.001 par value per share ("Common Stock")
2022-06-13$1.70/sh+100,000→ 10,523,188 total
Purchase
STANDARD BIOTOOLS INC.$LAB
Common Stock
2022-06-03$1.98/sh+250,000→ 10,423,188 total
Purchase
STANDARD BIOTOOLS INC.$LAB
Common Stock, $0.001 par value per share ("Common Stock")
2022-06-02$1.92/sh+200,000→ 10,173,188 total
Purchase
Liquidia Corp$LQDA
Common Stock, $0.001 par value per share ("Common Stock")
2022-05-25$3.40/sh+79,400→ 10,393,627 total
Purchase
Liquidia Corp$LQDA
Common Stock
2022-05-19$5.81/sh+85,000→ 10,314,227 total
Purchase
Liquidia Corp$LQDA
Common Stock
2022-05-18$5.89/sh+76,404→ 10,229,227 total
Purchase
Liquidia Corp$LQDA
Common Stock, $0.001 par value per share ("Common Stock")
2022-05-17$5.99/sh+59,700→ 10,152,823 total
Purchase
STANDARD BIOTOOLS INC.$LAB
Common Stock
2022-05-10$2.52/sh+25,000→ 9,973,188 total
Purchase
STANDARD BIOTOOLS INC.$LAB
Common Stock, $0.001 par value per share (Common Stock)
2022-05-06$2.90/sh+463,350→ 9,948,188 total
Purchase
STANDARD BIOTOOLS INC.$LAB
Common Stock
2022-05-02$2.81/sh+125,000→ 9,484,838 total
Purchase
STANDARD BIOTOOLS INC.$LAB
Common Stock
2022-04-29$2.66/sh+247,400→ 9,359,838 total
Purchase
STANDARD BIOTOOLS INC.$LAB
Common Stock, $0.001 par value per share ("Common Stock")
2022-04-28$2.40/sh+27,600→ 9,112,438 total
Purchase
Liquidia Corp$LQDA
Common Stock, $0.001 par value per share
2022-04-18$5.10/sh+1,764,705→ 10,093,123 total

JOHNSON DAVID EDWARD

Recent Transactions

Companies

Recent Filings

Address